GB0617581D0 - Biomarkers for assessing liver function - Google Patents

Biomarkers for assessing liver function

Info

Publication number
GB0617581D0
GB0617581D0 GBGB0617581.4A GB0617581A GB0617581D0 GB 0617581 D0 GB0617581 D0 GB 0617581D0 GB 0617581 A GB0617581 A GB 0617581A GB 0617581 D0 GB0617581 D0 GB 0617581D0
Authority
GB
United Kingdom
Prior art keywords
liver function
biomarkers
assessing liver
individual
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0617581.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB0617581.4A priority Critical patent/GB0617581D0/en
Publication of GB0617581D0 publication Critical patent/GB0617581D0/en
Priority to EA200970256A priority patent/EA200970256A1/ru
Priority to KR1020097007160A priority patent/KR20090083335A/ko
Priority to AU2007293302A priority patent/AU2007293302A1/en
Priority to MX2009002378A priority patent/MX2009002378A/es
Priority to PCT/GB2007/003362 priority patent/WO2008029145A1/en
Priority to JP2009527200A priority patent/JP4949473B2/ja
Priority to EP07804163A priority patent/EP2059817B1/en
Priority to ZA200901432A priority patent/ZA200901432B/xx
Priority to AT07804163T priority patent/ATE488772T1/de
Priority to ES07804163T priority patent/ES2353835T3/es
Priority to DE602007010644T priority patent/DE602007010644D1/de
Priority to CA002662597A priority patent/CA2662597A1/en
Priority to US12/440,170 priority patent/US8455220B2/en
Priority to IL197271A priority patent/IL197271A0/en
Priority to NO20090993A priority patent/NO20090993L/no
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
GBGB0617581.4A 2006-09-07 2006-09-07 Biomarkers for assessing liver function Ceased GB0617581D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB0617581.4A GB0617581D0 (en) 2006-09-07 2006-09-07 Biomarkers for assessing liver function
US12/440,170 US8455220B2 (en) 2006-09-07 2007-09-07 Biomarkers for assessing liver function
JP2009527200A JP4949473B2 (ja) 2006-09-07 2007-09-07 肝機能を評価するためのバイオマーカー
ZA200901432A ZA200901432B (en) 2006-09-07 2007-09-07 Biomarkers for assessing liver function
AU2007293302A AU2007293302A1 (en) 2006-09-07 2007-09-07 Biomarkers for assessing liver function
MX2009002378A MX2009002378A (es) 2006-09-07 2007-09-07 Biomarcadores para evaluar la funcion hepatica.
PCT/GB2007/003362 WO2008029145A1 (en) 2006-09-07 2007-09-07 Biqmarkers for assessing liver function
EA200970256A EA200970256A1 (ru) 2006-09-07 2007-09-07 Биомаркеры для определения функции печени
EP07804163A EP2059817B1 (en) 2006-09-07 2007-09-07 Biomarkers for assessing liver function
KR1020097007160A KR20090083335A (ko) 2006-09-07 2007-09-07 간 기능 평가용 바이오마커
AT07804163T ATE488772T1 (de) 2006-09-07 2007-09-07 Biomarker zur beurteilung der leberfunktion
ES07804163T ES2353835T3 (es) 2006-09-07 2007-09-07 Biomarcadores para evaluar la función hepática.
DE602007010644T DE602007010644D1 (de) 2006-09-07 2007-09-07 Biomarker zur beurteilung der leberfunktion
CA002662597A CA2662597A1 (en) 2006-09-07 2007-09-07 Biomarkers for assessing liver function
IL197271A IL197271A0 (en) 2006-09-07 2009-02-26 Biomarkers for assessing liver function
NO20090993A NO20090993L (no) 2006-09-07 2009-03-05 BIQ-markorer for vurdering av leverfunksjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0617581.4A GB0617581D0 (en) 2006-09-07 2006-09-07 Biomarkers for assessing liver function

Publications (1)

Publication Number Publication Date
GB0617581D0 true GB0617581D0 (en) 2006-10-18

Family

ID=37232490

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0617581.4A Ceased GB0617581D0 (en) 2006-09-07 2006-09-07 Biomarkers for assessing liver function

Country Status (16)

Country Link
US (1) US8455220B2 (cg-RX-API-DMAC7.html)
EP (1) EP2059817B1 (cg-RX-API-DMAC7.html)
JP (1) JP4949473B2 (cg-RX-API-DMAC7.html)
KR (1) KR20090083335A (cg-RX-API-DMAC7.html)
AT (1) ATE488772T1 (cg-RX-API-DMAC7.html)
AU (1) AU2007293302A1 (cg-RX-API-DMAC7.html)
CA (1) CA2662597A1 (cg-RX-API-DMAC7.html)
DE (1) DE602007010644D1 (cg-RX-API-DMAC7.html)
EA (1) EA200970256A1 (cg-RX-API-DMAC7.html)
ES (1) ES2353835T3 (cg-RX-API-DMAC7.html)
GB (1) GB0617581D0 (cg-RX-API-DMAC7.html)
IL (1) IL197271A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009002378A (cg-RX-API-DMAC7.html)
NO (1) NO20090993L (cg-RX-API-DMAC7.html)
WO (1) WO2008029145A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200901432B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012262329B2 (en) 2011-05-31 2014-10-16 The Regents Of The University Of Colorado, A Body Corporate Method for assessment of hepatic function and portal blood flow
CA3191764A1 (en) * 2012-11-12 2014-05-15 The Regents Of The University Of Colorado, A Body Corporate Disease severity index for assessment of chronic liver disease and method for diagnosis of three distinct subtypes of primary sclerosing cholangitis
US10054600B2 (en) 2013-05-22 2018-08-21 The Regents Of The University Of California Biomarker composite test for hepatic vein pressure gradient and cirrhosis treatment
CA2965325A1 (en) * 2014-10-24 2016-04-28 Mallinckrodt Hospital Products IP Limited Method of treating patients with hepatorenal syndrome type 1
CN105181692A (zh) * 2015-09-30 2015-12-23 山东博科生物产业有限公司 一种缺血修饰白蛋白比色法检测试剂盒
US10793909B2 (en) 2015-11-10 2020-10-06 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for predicting the survival time of patients with decompensated alcoholic cirrhosis
US20220018852A1 (en) * 2018-11-20 2022-01-20 Inserm (Institute National De Ka Santé Et De La Recherche Médicale) Methods and kits for detecting liver dysfunction in a subject

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034605A1 (en) 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
AU2001275870A1 (en) 2000-07-06 2002-01-21 Fal Diagnostics Methods and kits for the detection of arginine compounds
US7063782B2 (en) * 2001-11-26 2006-06-20 Ischemia Technologies, Inc. Electrochemical detection of ischemia
WO2004012686A2 (en) * 2002-08-06 2004-02-12 Nitromed, Inc. Nitrosated and/or nitrosylated ursodeoxycholic acid compounds, compositions and methods of use
WO2004046314A2 (en) 2002-11-15 2004-06-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
WO2005039598A1 (en) * 2003-10-24 2005-05-06 Intermune, Inc. Method of treating alcoholic liver disease
DE10351238A1 (de) * 2003-11-03 2005-06-02 Roche Diagnostics Gmbh Diagnosestellung von akuten myokardialen, ischämischen Erkrankungen durch Kombination von Markern

Also Published As

Publication number Publication date
CA2662597A1 (en) 2008-03-13
WO2008029145A1 (en) 2008-03-13
DE602007010644D1 (de) 2010-12-30
EP2059817A1 (en) 2009-05-20
ZA200901432B (en) 2010-06-30
IL197271A0 (en) 2009-12-24
KR20090083335A (ko) 2009-08-03
AU2007293302A1 (en) 2008-03-13
JP4949473B2 (ja) 2012-06-06
NO20090993L (no) 2009-04-03
US20090280519A1 (en) 2009-11-12
EP2059817B1 (en) 2010-11-17
ES2353835T3 (es) 2011-03-07
EA200970256A1 (ru) 2009-08-28
MX2009002378A (es) 2009-03-20
JP2010502979A (ja) 2010-01-28
ATE488772T1 (de) 2010-12-15
US8455220B2 (en) 2013-06-04

Similar Documents

Publication Publication Date Title
IL197271A0 (en) Biomarkers for assessing liver function
WO2008088652A3 (en) Method and system for generating a predictive analysis of the performance of peer reviews
GB2460092B (en) An insert kit and installation method
IL185261A0 (en) Method, apparatus and computer program for azimuth determination e.g. for autonomous navigation applications
WO2008064658A3 (de) Verfahren zum testen eines computerprogramms
WO2007124361A3 (en) Soluble b7-h1
WO2008063783A3 (en) Biomarkers related to metabolic age and methods using the same
GB0811422D0 (en) Efficient caching
IL200134A0 (en) Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
WO2009111127A3 (en) Location determination
WO2009037473A3 (en) Nucleobase characterisation
MX2010006240A (es) Sistemas y metodos para utilizar resultados de simulacion de flujo a base de celda para calcular trayectorias de linea de corriente.
MX2009004852A (es) Procedimiento para la determinacion de la fragmentacion del adn en microorganismos.
WO2006130292A3 (en) Image comparison by metric embeddings
AP2182A (en) Invoice financing.
WO2009085196A8 (en) Methods and compositions for correlating genetic markers with prostate cancer risk
WO2008034622A3 (en) A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator
GB0600916D0 (en) detecting and predicting pre-eclampsia
WO2006105170A3 (en) Systems and methods for determining cost of capital for an entity in a bottom-up, fully risk-based manner
DK2064185T3 (da) 1H-quinolin-4-on-forbindelser med affinitet til GABA-receptoren, fremgangsmåder, anvendelser og sammensætninger
NL1029419A1 (nl) Niveauverschuiver en werkwijze daarvoor.
MX2008009830A (es) Efecto del inhibidor bst2.
GB0505443D0 (en) Image processing methods
WO2011054327A3 (de) Anordnung zur positionierung von abgehängten profilen im trockenbau
WO2008059165A3 (fr) Methodes et outils pour determiner l'origine d'un sujet

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)